Clinical Trials Logo

Cognitive Dysfunction clinical trials

View clinical trials related to Cognitive Dysfunction.

Filter by:

NCT ID: NCT03811314 Completed - Dementia Clinical Trials

The Therapeutic Effect of Exercise Training on Patients With Dementia and Mild Cognitive Impairment

Start date: April 9, 2018
Phase: N/A
Study type: Interventional

This study aimed to clarify whether strength training or aerobic training could bring more benefits for patients with dementia, another study is to clarify whether isokinetic or isotonic training could bring more benefits for patients with mild cognitive impairment

NCT ID: NCT03811184 Recruiting - Alzheimer Disease Clinical Trials

Validation of a Smartphone Application for the Assessment of Patients With Mild Cognitive Impairment: MemScreen

MemScreen
Start date: January 17, 2019
Phase:
Study type: Observational

The clinical evaluation of a patient with a cognitive complaint requires neuropsychological tests, evaluating the integrity of memory and other cognitive functions. The initial evaluation is made most often by a doctor (general practitioner). In case of need for further examination, a neuropsychological report is made in consultation memory by a neuropsychologist, with further cognitive tests. The Cognitive Neurology Center at Lariboisière Hospital - Fernand Widal has developed a tool on a digital tablet or smartphone to evaluate cognitive functions: MemScreen. The purpose of this study is to validate this new neuropsychological test on tablet compared to the neuropsychological reference tests.

NCT ID: NCT03805880 Completed - Clinical trials for Cognitive Dysfunction

Cerebral Desaturation and Postoperative Dysfunction After Thoracic Surgery

Start date: January 1, 2018
Phase:
Study type: Observational

The purpose of this study prospective observational study is to determine cognitive dysfunction incidence after thoracic surgery. We also evaluate evaluate the role of cerebral oxygen desaturations and hypertension as risk factors for post-operative cognitive dysfunction (POCD) in patients undergoing lung resection.

NCT ID: NCT03805620 Completed - Clinical trials for Mild Cognitive Impairment

Effects of Combined Physical-cognitive Training on Cognitive Function in MCI

Start date: March 18, 2019
Phase: N/A
Study type: Interventional

The present study aims to investigate the effects of combined physical-cognitive training on cognitive function as well as peripheral BDNF level and mitochondrial function of individuals with MCI. It is hypothesized that: 1) the combined physical-cognitive training program will be superior to the physical and cognitive training program alone; and 2) the degree of cognitive improvement will be positively correlated with the improvement of plasma BDNF and mitochondrial function.

NCT ID: NCT03804840 Completed - Clinical trials for Measuring THC-induced Cognitive Impairment Using a Mobile Application

Developing a Mobile Method to Measure THC-induced Impairment

AIS
Start date: March 1, 2017
Phase: Early Phase 1
Study type: Interventional

Marijuana use, for both recreational and therapeutic purposes, is becoming increasingly common as states remove restrictions on use. The increased use raises new concern about the safety of this drug, including its ability to impair basic cognitive and psychomotor tasks, and whether the users are aware of their impairment. We propose to design a simple performance test that users can use in the field, using a cell phone, to assess their level of impairment relative to their own drug-free state. In this preliminary study, we will compare participants' simple task performance after a known dose of delta-9-tetrahydrocannabinol (THC), or placebo, administered under double-blind conditions. In our app the participants will be asked to gauge their own perceived level of impairment (as determined by self-ratings and judgments of impairment) as well as their actual impairment (as gauged by the app), providing important feedback and training about their ability to detect impairment.

NCT ID: NCT03804658 Recruiting - Cognitive Decline Clinical Trials

The Factors Affecting the Achievement of Glucose Monitor in the Patients on Diabetes

Start date: January 13, 2019
Phase:
Study type: Observational [Patient Registry]

To assess the effect of glucose monitors on glucose control and cardiovascular risks.

NCT ID: NCT03802396 Completed - Clinical trials for Postoperative Delirium

Modulating ApoE Signalling to Reduce Brain Inflammation, deLirium and postopErative Cognitive Dysfunction

MARBLE
Start date: July 15, 2018
Phase: Phase 2
Study type: Interventional

This research study will evaluate the effectiveness and estimate the feasibility of administering an investigational drug called 'CN-105' (the study drug), to prevent postoperative cognitive decline, delirium (serious confusion) and underlying brain inflammatory and brain activity changes in adults 60 years and older undergoing surgery.

NCT ID: NCT03795454 Completed - Clinical trials for Language Development

Can Singing Kangaroo Improve Outcome of Preterm Infants

SingKang
Start date: May 3, 2013
Phase: N/A
Study type: Interventional

To assess whether a musical intervention (maternal/paternal singing) during the skin-to-skin sessions (Kangaroo care) would improve the language development of the preterm infant. Infants will be randomized to singing or silence during the Kangaroo care from the age corresponding to 30th gestational week until term age (40 gestational weeks).

NCT ID: NCT03794427 Recruiting - Cognitive Decline Clinical Trials

Combined Lumbosacral Nerve Block Versus Spinal Anesthesia for Cognitive Function After Hip Prothesis

Start date: January 2, 2019
Phase: N/A
Study type: Interventional

Hip fracture is a potentially devastating event, and serious surgical and medical complications occur frequently especially for elderly patients. Delirium is one of the common complications after hip surgery. Controversy exists regarding the possible impact of type of anesthesia (nerve block versus spinal) upon acute and long-term cognitive decline. The primary objective is to assess the association between type of anesthesia (nerve block vs. spinal anesthesia) and risk of cognitive decline (CD). The secondary objective is to compare intra-operative hemodynamic changes, use of vasopressor drugs, and use of post-operative analgesics with respect to the type of anesthesia. Prospective, double blind randomized clinical trial of hip fracture patients who will be assessed for CD pre- and postoperatively, using the Mini Mental State Examination (MMSE). The presence of CD will be determined at follow-up evaluation up to three months after surgery.

NCT ID: NCT03793751 Completed - Clinical trials for Cognitive Dysfunction

Effect of Intraoperative Dexmedetomidine on Early Postoperative Cognitive Dysfunction

Start date: October 1, 2017
Phase: Phase 4
Study type: Interventional

This study will aim to identify the impact of Intraoperative dexmedetomidine infusion on POCD assessed by the Montreal Cognitive Assessment (MoCA) in geriatric patients above 60 years undergoing hip surgery under spinal anaesthesia.